Description overdue on 14.09.2011

International name of the drug - naphazoline . It refers to a group alpha-adrenergic agonists , Has a decongestant, vasoconstrictor effect. Available in the form nasal drops   or metered nasal spray . Naphthyzinum provide quick, sustained and marked narrowing of blood vessels in the nasal mucosa, reduces swelling, reduces exudation . hyperemia . Regular use of the drug for a week leads to the development of tolerance.

Indications:

Sinusitis , Acute rhinitis, laryngitis , Evstahiit, nasal allergy , Laryngeal edema as a result of irradiation, allergies , Chronic conjunctivitis. Naphthyzinum applied in order to facilitate the procedure rinoskopii To nose bleeding stopped, and as an aid in bacterial conjunctivitis genesis.

Contraindications:

Naphthyzinum is contraindicated in case of hypersensitivity to naphazoline, atherosclerosis, hypertension, hyperthyroidism, diabetes mellitus, severe eye disease, chronic rhinitis. Naphthyzinum can not be used for children under a year. Contraindications acts and concomitant use of drugs from the group of MAO inhibitors ( monoamine oxidase ), And the period up to 2 weeks to complete their reception.

Side effects:

Perhaps the development of tachycardia, nausea, increased blood pressure, migraine . With regular use naftizina than 1 week may develop atrophic rhinitis, edema of the mucosa of the nasal cavity.

Overdose:

Symptoms: bradycardia . hypothermia . increased blood pressure . Treatment is symptomatic.

Mode of application:

In otorhinolaryngology: adults - 1-3 drops of solution (0, 05-0, 1%) to three isolator day. For Kids: into the nasal cavity is instilled 0, 025-0, 05% solution. Children from year to 6 years naftizina recommended dose - 1-2 Cap. Children from 6 to 15 years - up to three times a day 2 drops. C diagnostic purpose after purification nasal passages instilled to on 3-4 k. For oteke, hyperemia voice ligaments drug is injected small doses using the Blingee laryngeal syringe, either in form of a spray in an amount 1-2 ml. If bleeding is administered swabs, pre-moistened with 0, 05% aqueous solution. In ophthalmology: conjunctiva injected into the cavity of 1-2 Cap. 0 05% solution, up to three times a day. As an additional drug for the purpose of surface anesthesia administered 2-4 cap. per 1 ml of the anesthetic agent.

Special instructions:

The drug is is capable of to render resorptive effects . Tolerated sterilization solution of drug (after removal of the pads, drip valve) at a temperature of 115-116 ° C in a water saturated steam for half an hour. With prolonged use, there is a decrease of severity naftizina vasoconstrictor effect. When using the drug within a week is necessary to to make a break. Naphthyzinum used during pregnancy is allowed, but not recommended. Similarly, women who are breastfeeding.

Connectivity:

The drug reduces the absorption of local anesthetics, resulting in lengthening the period of their exposure at the surface anesthesia. It is not recommended to use simultaneously Naphthyzinum inhibitors and MAO (monoamine oxidase), and 10 days after their reception. Naphthyzinum reduces efficiency antihypertensives , Enhances the effect of sedatives and sleeping pills.

Store at 10-25 ° C, in a dark place, of the reach for children. The drug must be protected from freezing.